MSCs have a potential role in ARDS

Mesenchymal stromal cells have the potential to become a revolutionary treatment for acute respiratory syndrome, an animal study has shown, but there are many challenges in translating the findings to clinical practice, editorialists say. The study by researchers from the University of Toronto found that rodents with Escherichia coli induced lung injury who were treated with human bone-marrow derived MSCs had improved ...

Already a member?

Login to keep reading.

© 2021 the limbic